Histoire culturelle et représentations transversales de Crans-Montana (1896-2014) : paysages, arts visuels, architecture, littérature et cinéma

La station valaisanne de Crans-Montana est richement représentée par la photographie, la peinture, les affiches et l'architecture. Cette thèse de doctorat s'emploie à réunir un large corpus de photographies et de représentations : peintures, affiches, cartes postales et reproductions de bâtiments emblématiques (voir le corpus illustré et documentaire annexé). Les questions liées à l'identité du territoire et son image sont les fils conducteurs de ce travail qui a débuté en 2008. Un premier ensemble visuel a été réuni par le Dr Théodore Stephani (1868-1951), un acteur fondamental pour l'histoire de la naissance de la station. Médecin, mais également photographe, il réalise une collection de plus de 1300 clichés, réunie en six albums, sur une période de trente-sept ans (1899-1936). Les photographies du médecin, originaire de Genève, fondateur de ce lieu désormais touristique sont le point de départ de cette recherche et son fil rouge. Celle-ci tentera d'articuler des représentations sur l'évolution du paysage et l'urbanisation de la station autour d'acteurs illustres, tels que les peintres Ferdinand Hodler (1853-1918) et Albert Muret (1874-1955), l'écrivain Charles-Ferdinand Ramuz (1878-1947) et les nombreux hôteliers ou médecins qui ont marqué l'histoire de la naissance du Haut-Plateau. Les représentations débutent en 1896 car c'est à ce moment-là que le Dr Stephani s'établit à Montana. Les architectes les plus connus de la première période sont François-Casimir Besson (1869-1944), Markus Burgener (1878-1953), suivi de la deuxième génération autour de Jean-Marie Ellenberger (1913-1988), André Perraudin (1915-2014) et André Gaillard (1921-2010). Parallèlement ou avant eux, les peintres déjà cités, Ferdinand Hodler et Albert Muret, - suivis de René Auberjonois (1872-1957), Henri-Edouard Bercher (1877-1970), Charles-Clos Olsommer (1883-1966), Oskar Kokoschka (1886-1980), Albert Chavaz (1907¬1990), Paul Monnier (1907-1982) et Hans Emi (1909-2015) - qui appartiennent tous à l'histoire culturelle de la région. Quant aux écrivains qui ont résidé dans la région, nous citons Elizabeth von Arnim (1866-1941), sa cousine Katherine Mansfield (1888-1923) alors que l'oeuvre de Charles-Ferdinand Ramuz est largement développée par une interprétation de son oeuvre Le Règne de l'esprit malin (1917) et un clin d'oeil pour Igor Stravinsky (1882¬1971). Nous présenterons aussi les films de trois cinéastes qui se sont inspirés des oeuvres écrites par Ramuz lors de son passage à Lens, à savoir Dimitri Kirsanoff (1899-1957), Claude Goretta (1929) et Francis Reusser (1942). Le concept du « village » est abordé depuis l'exposition nationale suisse (1896) jusqu'au projet des investisseurs russes, à Aminona. Ce « village » est le deuxième mégaprojet de Suisse, après celui d'Andermatt. Si le projet se réalise, l'image de la station s'en trouvera profondément transformée. En 1998, la publication de Au bord de la falaise. L'histoire entre certitudes et inquiétudes amène une grande visibilité aux propositions de Roger Chartier, qui lie l'étude des textes aux objets matériels et les usages qu'ils engendrent dans la société. Il définit l'histoire culturelle comme "une histoire culturelle du social" alors que pour Pascal Ory, une histoire culturelle est "comme une forme d'histoire sociale", ce qui revient presque au même, mais nous choisirons celle d'Ory pour une histoire sociale du paysage et de l'architecture. Ce travail adopte ainsi plusieurs points de vue : l'histoire sociale, basée sur les interviews de nombreux protagonistes de l'histoire locale, et l'histoire de l'art qui permet une sélection d'objets emblématiques ; l'histoire culturelle offre ainsi une méthode transversale pour lire et relier ces différents regards ou points de vue entre les paysages, les arts visuels, l'architecture, la littérature et le cinéma.

Governance mode vs. governance fit: Performance implications of make-or-ally choices for product innovation in the worldwide aircraft industry, 1942-2000

We examine the impact of governance mode and governance fit on performance in make-or-ally decisions. We argue that while horizontal collaboration and autonomous governance have direct and countervailing performance implications, the alignment of make-or-ally choices with the focal firm's resource endowment and the activity's resource requirements leads to better performance. Data on the aircraft industry show that relative to aircraft developed autonomously, collaborative aircraft exhibit greater sales but require longer time-to-market. However, governance fit increases unit sales and reduces time-to-market. We contribute to the alliance and economic organization literatures. (Copyright © 2013 John Wiley & Sons, Ltd.)

Hepatitis C Virus Infection and Kidney Transplantation in 2014: What's New?

Chronic hepatitis C virus (HCV) infection remains an important health problem, which is associated with deleterious consequences in kidney transplant recipients. Besides hepatic complications, several extrahepatic complications contribute to reduced patient and allograft survival in HCV-infected kidney recipients. However, HCV infection should not be considered as a contraindication for kidney transplantation because patient survival is better with transplantation than on dialysis. Treatment of HCV infection is currently interferon-alpha (IFN-α) based, which has been associated with higher renal allograft rejection rates. Therefore, antiviral treatment before transplantation is preferable. As in the nontransplant setting, IFN-free treatment regimens, because of their greater efficacy and reduced toxicity, currently represent promising and attractive therapeutic options after kidney transplantation as well. However, clinical trials will be required to closely evaluate these regimens in kidney recipients. There is also a need for prospective controlled studies to determine the optimal immunosuppressive regimens after transplantation in HCV-infected recipients. Combined kidney and liver transplantation is required in patients with advanced liver cirrhosis. However, in patients with cleared HCV infection and early cirrhosis without portal hypertension, kidney transplantation alone may be considered. There is some agreement about the use of HCV-positive donors in HCV-infected recipients, although data regarding posttransplant survival rates are controversial.

Antidoping programme and biological monitoring before and during the 2014 FIFA World Cup Brazil.

BACKGROUND: The FIFA has implemented an important antidoping programme for the 2014 FIFA World Cup. AIM: To perform the analyses before and during the World Cup with biological monitoring of blood and urine samples. METHODS: All qualified players from the 32 teams participating in the World Cup were tested out-of-competition. During the World Cup, 2-8 players per match were tested. Over 1000 samples were collected in total and analysed in the WADA accredited Laboratory of Lausanne. RESULTS: The quality of the analyses was at the required level as described in the WADA technical documents. The urinary steroid profiles of the players were stable and consistent with previously published papers on football players. During the competition, amphetamine was detected in a sample collected on a player who had a therapeutic use exemption for attention deficit hyperactivity disorder. The blood passport data showed no significant difference in haemoglobin values between out-of-competition and postmatch samples. CONCLUSIONS: Logistical issues linked to biological samples collection, and the overseas shipment during the World Cup did not impair the quality of the analyses, especially when used as the biological passport of football players.

Traitement de l'ischémie critique chronique des membres inférieurs en 2014 [Treatment of critical lower limb ischemia].

Critical limb ischemia is a major public health problem in our western countries due to the epidemia of (diabesity). The outcome of patients suffering from critical limb ischemia reains poor with an amputation free survival rate at one year of about 50%. The treatment should be multidiciplinary and done in emergency in specialized centers to ensure the limb salvage: this management should be centered aroud 3 axis: the screening of the cardiovascular risk factors, the best medical treatment and the invasive approaches. Due to multiple endovascular technical innovations, more frail patients with com plex diseases can be treated with good results. Therefore, the endovascular treatment is essential in the management of such patients by vascular surgeons.

arrayMap 2014: an updated cancer genome resource.

Somatic copy number aberrations (CNA) represent a mutation type encountered in the majority of cancer genomes. Here, we present the 2014 edition of arrayMap (http://www.arraymap.org), a publicly accessible collection of pre-processed oncogenomic array data sets and CNA profiles, representing a vast range of human malignancies. Since the initial release, we have enhanced this resource both in content and especially with regard to data mining support. The 2014 release of arrayMap contains more than 64,000 genomic array data sets, representing about 250 tumor diagnoses. Data sets included in arrayMap have been assembled from public repositories as well as additional resources, and integrated by applying custom processing pipelines. Online tools have been upgraded for a more flexible array data visualization, including options for processing user provided, non-public data sets. Data integration has been improved by mapping to multiple editions of the human reference genome, with the majority of the data now being available for the UCSC hg18 as well as GRCh37 versions. The large amount of tumor CNA data in arrayMap can be freely downloaded by users to promote data mining projects, and to explore special events such as chromothripsis-like genome patterns.

Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.

IMPORTANCE: New data and antiretroviral regimens expand treatment choices in resource-rich settings and warrant an update of recommendations to treat adults infected with human immunodeficiency virus (HIV). OBJECTIVE: To provide updated treatment recommendations for adults with HIV, emphasizing when to start treatment; what treatment to start; the use of laboratory monitoring tools; and managing treatment failure, switches, and simplification. DATA SOURCES, STUDY SELECTION, AND DATA SYNTHESIS: An International Antiviral Society-USA panel of experts in HIV research and patient care considered previous data and reviewed new data since the 2012 update with literature searches in PubMed and EMBASE through June 2014. Recommendations and ratings were based on the quality of evidence and consensus. RESULTS: Antiretroviral therapy is recommended for all adults with HIV infection. Evidence for benefits of treatment and quality of available data increase at lower CD4 cell counts. Recommended initial regimens include 2 nucleoside reverse transcriptase inhibitors (NRTIs; abacavir/lamivudine or tenofovir disoproxil fumarate/emtricitabine) and a third single or boosted drug, which should be an integrase strand transfer inhibitor (dolutegravir, elvitegravir, or raltegravir), a nonnucleoside reverse transcriptase inhibitor (efavirenz or rilpivirine) or a boosted protease inhibitor (darunavir or atazanavir). Alternative regimens are available. Boosted protease inhibitor monotherapy is generally not recommended, but NRTI-sparing approaches may be considered. New guidance for optimal timing of monitoring of laboratory parameters is provided. Suspected treatment failure warrants rapid confirmation, performance of resistance testing while the patient is receiving the failing regimen, and evaluation of reasons for failure before consideration of switching therapy. Regimen switches for adverse effects, convenience, or to reduce costs should not jeopardize antiretroviral potency. CONCLUSIONS AND RELEVANCE: After confirmed diagnosis of HIV infection, antiretroviral therapy should be initiated in all individuals who are willing and ready to start treatment. Regimens should be selected or changed based on resistance test results with consideration of dosing frequency, pill burden, adverse toxic effect profiles, comorbidities, and drug interactions.